L'evoluzione dei criteri diagnostici per la sclerosi multipla non ha modificato la quota di pazienti con bande oligoclonali nel liquor

Translated title of the contribution: The evolution of diagnostic criteria for multiple sclerosis (MS) did not change the rate of patients displaying oligoclonal bands in the cerebrospinal fluid (CSF)

Emilio Ciusani, Monica Lazzaroni, Francesca Gilardoni, Fulvio Baggi, Paolo Confalonieri, Rita Frangiamore, Renato Mantegazza, Andrea Salmaggi, Gaetano Bernardi

Research output: Contribution to journalArticle

Abstract

The early diagnosis of MS, an inflammatory disease of the central nervous system, can be difficult. Although a specific laboratory test is lacking, the presence of CSF-restricted oligoclonal bands has been reported in the majority of patients (80-95%); as a consequence, this test has been included in the diagnostic criteria for many years. However, after each revision of the diagnostic criteria, the relevance of this test has progressively lost in importance, while magnetic resonance imaging has gained a central role. In the present study, two groups of MS patients diagnosed with McDonald (2001 and subsequent revisions) or with Poser (1983) criteria (176 and 82, respectively) were compared with regard to the frequency of the presence of oligoclonal bands in CSF. The same method for the oligoclonal pattern detection, based on isoelectric focusing followed by blotting and immunodetection of IgG, was used on both groups. Results showed that the rate of patients displaying CSF-restricted oligoclonal bands was 89.0% and 89.8% in the two groups, respectively (P=0.57). Our data suggest that the percentage of MS patients with CSF-restricted oligoclonal bands was unchanged and independent of the diagnostic criteria. Furthermore, the results suggest that the different MS diagnostic criteria considered (Poser vs. McDonald) identify patients with a similar immunological background.

Original languageItalian
Pages (from-to)213-217
Number of pages5
JournalBiochimica Clinica
Volume38
Issue number3
Publication statusPublished - 2014

Fingerprint

Oligoclonal Bands
Cerebrospinal fluid
Multiple Sclerosis
Cerebrospinal Fluid
Neurology
Magnetic resonance
Central Nervous System Diseases
Isoelectric Focusing
Immunoglobulin G
Early Diagnosis
Imaging techniques
Magnetic Resonance Imaging

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Biochemistry, medical
  • Medical Laboratory Technology

Cite this

L'evoluzione dei criteri diagnostici per la sclerosi multipla non ha modificato la quota di pazienti con bande oligoclonali nel liquor. / Ciusani, Emilio; Lazzaroni, Monica; Gilardoni, Francesca; Baggi, Fulvio; Confalonieri, Paolo; Frangiamore, Rita; Mantegazza, Renato; Salmaggi, Andrea; Bernardi, Gaetano.

In: Biochimica Clinica, Vol. 38, No. 3, 2014, p. 213-217.

Research output: Contribution to journalArticle

@article{c27599c5663345a8b0b18191e77f0a06,
title = "L'evoluzione dei criteri diagnostici per la sclerosi multipla non ha modificato la quota di pazienti con bande oligoclonali nel liquor",
abstract = "The early diagnosis of MS, an inflammatory disease of the central nervous system, can be difficult. Although a specific laboratory test is lacking, the presence of CSF-restricted oligoclonal bands has been reported in the majority of patients (80-95{\%}); as a consequence, this test has been included in the diagnostic criteria for many years. However, after each revision of the diagnostic criteria, the relevance of this test has progressively lost in importance, while magnetic resonance imaging has gained a central role. In the present study, two groups of MS patients diagnosed with McDonald (2001 and subsequent revisions) or with Poser (1983) criteria (176 and 82, respectively) were compared with regard to the frequency of the presence of oligoclonal bands in CSF. The same method for the oligoclonal pattern detection, based on isoelectric focusing followed by blotting and immunodetection of IgG, was used on both groups. Results showed that the rate of patients displaying CSF-restricted oligoclonal bands was 89.0{\%} and 89.8{\%} in the two groups, respectively (P=0.57). Our data suggest that the percentage of MS patients with CSF-restricted oligoclonal bands was unchanged and independent of the diagnostic criteria. Furthermore, the results suggest that the different MS diagnostic criteria considered (Poser vs. McDonald) identify patients with a similar immunological background.",
author = "Emilio Ciusani and Monica Lazzaroni and Francesca Gilardoni and Fulvio Baggi and Paolo Confalonieri and Rita Frangiamore and Renato Mantegazza and Andrea Salmaggi and Gaetano Bernardi",
year = "2014",
language = "Italian",
volume = "38",
pages = "213--217",
journal = "Biochimica Clinica",
issn = "0393-0564",
publisher = "CLAS International",
number = "3",

}

TY - JOUR

T1 - L'evoluzione dei criteri diagnostici per la sclerosi multipla non ha modificato la quota di pazienti con bande oligoclonali nel liquor

AU - Ciusani, Emilio

AU - Lazzaroni, Monica

AU - Gilardoni, Francesca

AU - Baggi, Fulvio

AU - Confalonieri, Paolo

AU - Frangiamore, Rita

AU - Mantegazza, Renato

AU - Salmaggi, Andrea

AU - Bernardi, Gaetano

PY - 2014

Y1 - 2014

N2 - The early diagnosis of MS, an inflammatory disease of the central nervous system, can be difficult. Although a specific laboratory test is lacking, the presence of CSF-restricted oligoclonal bands has been reported in the majority of patients (80-95%); as a consequence, this test has been included in the diagnostic criteria for many years. However, after each revision of the diagnostic criteria, the relevance of this test has progressively lost in importance, while magnetic resonance imaging has gained a central role. In the present study, two groups of MS patients diagnosed with McDonald (2001 and subsequent revisions) or with Poser (1983) criteria (176 and 82, respectively) were compared with regard to the frequency of the presence of oligoclonal bands in CSF. The same method for the oligoclonal pattern detection, based on isoelectric focusing followed by blotting and immunodetection of IgG, was used on both groups. Results showed that the rate of patients displaying CSF-restricted oligoclonal bands was 89.0% and 89.8% in the two groups, respectively (P=0.57). Our data suggest that the percentage of MS patients with CSF-restricted oligoclonal bands was unchanged and independent of the diagnostic criteria. Furthermore, the results suggest that the different MS diagnostic criteria considered (Poser vs. McDonald) identify patients with a similar immunological background.

AB - The early diagnosis of MS, an inflammatory disease of the central nervous system, can be difficult. Although a specific laboratory test is lacking, the presence of CSF-restricted oligoclonal bands has been reported in the majority of patients (80-95%); as a consequence, this test has been included in the diagnostic criteria for many years. However, after each revision of the diagnostic criteria, the relevance of this test has progressively lost in importance, while magnetic resonance imaging has gained a central role. In the present study, two groups of MS patients diagnosed with McDonald (2001 and subsequent revisions) or with Poser (1983) criteria (176 and 82, respectively) were compared with regard to the frequency of the presence of oligoclonal bands in CSF. The same method for the oligoclonal pattern detection, based on isoelectric focusing followed by blotting and immunodetection of IgG, was used on both groups. Results showed that the rate of patients displaying CSF-restricted oligoclonal bands was 89.0% and 89.8% in the two groups, respectively (P=0.57). Our data suggest that the percentage of MS patients with CSF-restricted oligoclonal bands was unchanged and independent of the diagnostic criteria. Furthermore, the results suggest that the different MS diagnostic criteria considered (Poser vs. McDonald) identify patients with a similar immunological background.

UR - http://www.scopus.com/inward/record.url?scp=84904659862&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84904659862&partnerID=8YFLogxK

M3 - Articolo

AN - SCOPUS:84904659862

VL - 38

SP - 213

EP - 217

JO - Biochimica Clinica

JF - Biochimica Clinica

SN - 0393-0564

IS - 3

ER -